Global Cord Blood (NYSE:CO) Stock Falls 0.1% – Should You Sell?

Shares of Global Cord Blood Co. (NYSE:CO – Get Free Report) dropped 0.1% during mid-day trading on Tuesday. The company traded as low as $0.95 and last traded at $0.95. Approximately 20,000 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 216,519 shares. The stock had previously closed at $0.9510.

Global Cord Blood Stock Down 0.1%

The company has a 50-day moving average of $0.95 and a 200 day moving average of $0.96. The firm has a market capitalization of $115.47 million, a PE ratio of 1.48 and a beta of 0.16.

About Global Cord Blood

(Get Free Report)

Global Cord Blood Corporation, formerly known as China Cord Blood Corporation, was a China-based provider of umbilical cord blood banking services. The company collected, tested, processed and cryopreserved cord blood stem cells for families seeking long-term storage and for patients requiring stem-cell transplants.

Through its operating subsidiaries and affiliated cord blood banks, the company served customers in several major Chinese markets, including Beijing, Guangdong and Zhejiang.

See Also

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.